{"id":1432,"date":"2016-09-07T16:56:26","date_gmt":"2016-09-07T20:56:26","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=1432"},"modified":"2016-09-07T16:56:26","modified_gmt":"2016-09-07T20:56:26","slug":"secondaries-announced-9-7-2016","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-9-7-2016\/","title":{"rendered":"Secondaries announced 9.7.2016"},"content":{"rendered":"

IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. <\/p>\n

Company: \tSage Therapeutics, Inc.
\nSymbol: \tSAGE
\nPrice: \t\tLast trade $41.34
\nTrade Date: \t9\/9
\nShares: \t3.63 million
\nUnderwriter(s) J.P. Morgan, Goldman Sachs
\nCo Manager(s) Canaccord Genuity
\nRating=Subscription Needed<\/a><\/p>\n

Company: \tHealthcare Trust of America, Inc.
\nSymbol: \tHTA
\nPrice: \t\tLast trade $34.64
\nDescription: \tRe-offer $33.60-$33.95
\nTrade Date: \t9\/8
\nShares: \t3.5 million
\nUnderwriter(s) Wells Fargo Securities, Jefferies, BMO Capital Markets
\nRating=Subscription Needed<\/a><\/p>\n

Company: \tWestern Refining Logistics
\nSymbol: \tWNRL
\nPrice: \t\tLast trade $24.26
\nDescription: \tRe-offer range $22.32-$22.80
\nTrade Date: \t9\/8
\nShares: \t5.25 million
\nUnderwriter(s) Barclays
\nRating=Subscription Needed<\/a><\/p>\n

Company: \tAmerican Homes 4 Rent
\nSymbol: \tAMH
\nPrice: \t\tLast trade $22.77
\nDescription: \tRe-offer $21.50-$22.00
\nTrade Date: \t9\/8
\nShares: \t43.5 million
\nUnderwriter(s) BofA Merrill Lynch
\nRating=Subscription Needed<\/a><\/p>\n

Company: \tXenon Pharmaceuticals
\nSymbol: \tXENE
\nPrice: \t\tLast trade $8.01
\nDescription: \tRe-offer $7.50-$7.75
\nTrade Date: \t9\/8
\nShares: \t3.12 million
\nUnderwriter(s) Jefferies, Stifel, Guggneheim Securities
\nRating=Subscription Needed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. Company: Sage Therapeutics, Inc. Symbol: SAGE Price: Last trade $41.34 Trade Date: 9\/9 Shares: 3.63 million Underwriter(s) J.P. Morgan, Goldman Sachs Co[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[891,786,310,817,892],"class_list":["post-1432","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-amh","tag-hta","tag-sage","tag-wnrl","tag-xene"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1432","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=1432"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1432\/revisions"}],"predecessor-version":[{"id":1433,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1432\/revisions\/1433"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=1432"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=1432"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=1432"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}